Saint Louis Encephalitis Virus, Brazil by Mondini, Adriano et al.
LETTERS
176 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 1, January 2007
the present study, PARV4 and PARV5
have been identified in blood samples
obtained from persons from the United
Kingdom. For parvovirus B19, there is
evidence of persistent virus infection,
at low levels, in bone marrow of previ-
ously exposed persons (7) and in plas-
ma of immunocompromised and
immunocompetent persons (8,9).
There is also evidence for the lifelong
persistence of parvovirus B19 (geno-
types 1 and 2) in tissues such as skin
and synovia (10). PARV4 and PARV5
virus genomes share only limited
homology with parvovirus B19 (<30%
amino acid similarity). Although they
have been detected in blood and plas-
ma, nothing is known about the role of
these viruses in human disease or their
ability to persist in infected persons,
healthy or otherwise. Further studies
will be required to determine the
prevalence of PARV4 and PARV5 in
healthy persons compared with its
prevalence in those with chronic infec-
tions and at high risk, such as IVDUs,
and to investigate the nature of persist-
ence of these novel viruses.
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Saint Louis
Encephalitis Virus,
Brazil 
To the Editor: Saint Louis
encephalitis virus (SLEV), a member
of the Flaviviridae family, is widely
dispersed in the Americas (1,2). In
Brazil, SLEV was first isolated in the
1960s from a pool of mosquitoes at the
Amazon Basin. Subsequently, the
virus was repeatedly isolated from ani-
mals and arthropods in the Amazon
region and São Paulo state (3).
Nonetheless, isolation of SLEV from
humans is rare; only 2 isolates from
humans were described before 2005.
Each isolate was from a patient who
had jaundice and febrile illness with-
out any neurologic symptoms (1,3).
Recently in São Paulo, SLEV was iso-
lated from a patient who had an incor-
rect diagnosis of dengue fever (2,4).
Despite the rare isolation of
SLEV from humans, antibodies to this
virus have been found in ≈5% of stud-
ied populations in the north and
southeast regions of Brazil. However,
because of antibody cross-reactivity
among different flaviviruses and the
fact that this population is vaccinated
against yellow fever and exposed to
dengue virus (DENV), such results
should be interpreted carefully.
Nevertheless, in these areas, SLEV
may circulate and infect humans,
although most infections are undiag-
nosed (1,3,5).
In contrast to previous instances
in which the disease was detected in
only 1 patient, we describe the first
community outbreak of SLEV in
Brazil. The outbreak was detected in
São José do Rio Preto (population
400,000), in northwest São Paulo
state. This outbreak was concurrent
with a large outbreak of DENV
serotype 3 (DENV-3), which occurred
during the first half of 2006, with
>15,000 possible cases reported to
public health authorities. During this
time, we were involved in an epidemi-
ologic study to monitor the disease.
We tested ≈250 samples for DENV,
and 65% were positive. We tested for
SLEVonly those patients who were in
our hospital or those who were
referred to us for SLEV testing after
an initial diagnosis of SLEV or
DENV. The protocol approved by our
ethical committee allowed us to test
only samples from these patients
(process no. 300/2004).LETTERS
We used a multiplex nested
reverse transcription–PCR (RT-PCR)
assay to identify the most common
flaviviruses in Brazil (DENV-1,
DENV-2, DENV-3, yellow fever
virus) as well as DENV-4, Ilheus
virus, Iguape virus, Rocio virus, and
SLEV. Of 54 samples (49 serum and 5
cerebrospinal fluid [CSF]) that were
negative for DENV and yellow fever
virus, SLEV RNA was detected in 6
(4 serum and 2 CSF) (6). RT-PCR
results were negative for all other test-
ed flaviviruses. Sequences of the
amplified SLEV cDNAs from the 2
CSF samples were determined by
using an ABI377 automated
sequencer (Applied Biosystems,
Foster City, CA, USA). The resulting
sequences (GenBank accession nos.
DQ836336 and DQ836337) were
identical and showed 96% homology
to an Argentinean SLEV isolate
(AY6-32544). All 6 SLEV-infected
patients had an initial diagnosis of
dengue fever or viral encephalitis; 3
had a diagnosis of viral meningoen-
cephalitis, and the other 3 had signs of
hemorrhagic disease (Table).
Dengue is widely disseminated in
Brazil and causes large outbreaks
almost every year. The high preva-
lence of antibodies in the Brazilian
population (1,3,6) suggests that SLEV
infections are being misdiagnosed; its
importance is underestimated. Brazil
has no SLEV surveillance programs,
and health professionals do not usual-
ly consider SLEV among their differ-
ential diagnoses. This SLEV outbreak
was detected in a large urban center
and was not specifically linked to
patients who dwell in pockets of trop-
ical forests, as previously reported
(1–4).
This outbreak may represent the
first time that hemorrhagic signs have
been linked to SLEV infections.
SLEV-associated hemorrhagic mani-
festations have not been reported in
the literature. However, of our 6
SLEV-infected patients, 3 had hemor-
rhagic signs. Substantiating a causal
link between SLEV infection and
such clinical manifestations is diffi-
cult because DENV is endemic in the
studied region (7). Possibly, SLEV-
infected patients with hemorrhagic
signs may have been previously
infected by DENV. No reports have
linked hemorrhagic manifestations to
sequential DENV and SLEV infec-
tions; this possible link needs to be
carefully evaluated.
In Argentina, SLEV has been iso-
lated several times from animals (8).
In some regions, SLEV seropreva-
lence in humans is ≈13% (9), but the
number of documented human infec-
tions is small (10). These findings
indicate either that SLEV is more
prevalent than reported or that SLEV
is reemerging. The Brazilian cases
may parallel the situation in
Argentina.
Our results clearly indicate an
SLEV outbreak among this local pop-
ulation in Brazil. This outbreak differs
from isolated infections previously
described and indicates that this dis-
ease may be more prevalent in Brazil.
In fact, the number of samples tested
for SLEV during this DENV outbreak
was relatively small. Had more sam-
ples been investigated, more cases of
SLEV infection might have been
found. A more comprehensive epi-
demiologic study is required to fully
assess the magnitude of SLEV infec-
tion in Brazil.
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Cryptococcus gattii
Risk for Tourists
Visiting Vancouver
Island, Canada
To the Editor:An unprecedented
outbreak of Cryptococcus gattii geno-
type amplified fragment length poly-
morphism (AFLP) 6/VGII on
Vancouver Island, British Columbia,
Canada, is affecting both human and
animal hosts with normal immunity
(1–3). So far, >100 human cases,
including at least 6 fatalities, have
been reported by the British Columbia
Centre for Disease Control (4),
(www.bccdc.org, www.cbc.ca). Van-
couver Island is a major tourist desti-
nation, with ≈7.5 million visits each
year (www.bcstats.gov.bc.ca). We
report the first known intercontinental
transmission of C. gattii from this out-
break in a tourist from Denmark who
visited Vancouver Island. This case
indicates a potential risk for tourism-
related acquisition.
A 51-year-old, HIV-negative,
apparently immunocompetent man
from Denmark, with known psoriatic
gout and under treatment with a nons-
teroidial antiinflammatory drug, was
admitted to a hospital in Herning,
Denmark, with chest pain radiating to
the left shoulder and arm, lasting for 1
day. Six weeks before his admission,
he returned to Denmark from a 3-
week trip to Canada, during which he
visited Victoria and surrounding areas
on the eastern coast of Vancouver
Island for 7 days. During their stay,
the patient and his 3 fellow travelers
visited gardens and studied the local
natural vegetation.
During his stay in Canada, the
patient had no symptoms, and symp-
toms had not developed in any of his
family members as of October 2006.
On admission to the hospital, his tem-
perature was 38.2°C, and a chest radi-
ograph showed 3 large nodular infil-
trates suspect for malignancy or
abscesses. Neither bacterial nor
1These authors contributed equally to this
work.